Patent classifications
A61L26/0004
EYE SERUM COMPOSITIONS, METHODS OF PREPARING, AND METHODS OF USE
Methods for preparing an eye serum formulation are disclosed. The methods include electrolyzing a saline solution having a salt concentration between about 0.01% and about 1.0% by weight using a voltage between about 0 V and about 30 V across an inert anode and a spaced apart inert cathode to generate a target mixture of chemically reduced and oxidized molecules within the saline solution, mirroring the target mixture of chemically reduced and oxidized species in the electrolyzed saline solution to the reduced species and reactive oxygen species found in a known biological system, adding a rheology modifier, adding a buffering agent, and adding a silicone oil. The target mixture of chemically reduced and oxidized molecules comprises one or more of hypochlorous acid, hypochlorites, dissolved oxygen, chlorine, hydrogen gas, hydrogen peroxide, hydrogen ions, hypochloride, superoxides, ozone, activated hydrogen ions, chloride ions, hydroxides, singlet oxygen, *OCl, and *HO.
HYPOCHLORITE FORMULATIONS FOR WOUND HEALING
A formulation is disclosed for use in wound healing. The formulation may include hypochlorous acid, a silicone polymer or blend thereof, sodium phosphate, hydrochloric acid, and sodium magnesium silicate. Methods of using and making the wound healing formulation are also disclosed.
Multi-Functional Cleaning and/or Debridement Composition
The present invention relates to a new multifunctional debridement and/or antifouling composition comprising H.sub.2O.sub.2 at a final concentration of between 0.1-5% v/v, and a composite hydrogel formulation comprising pluronic acid at a concentration of 10-40% w/v, wherein the composition is in liquid form at room temperature. The composition disclosed herein is antimicrobial and/or anti-inflammatory and is particular useful in periimplantitis treatment and implant health maintenance, in periodontitis and periodontal health and in wound care and chronic ulcer care.
Wound Dressings and Methods of Making the Same
An article and a method of making the article. The article can include a conformable matrix comprising a mixture of collagen, bioactive glass, and an additive selected from cellulose and/or alginate; wherein the article is a conformable wound dressing. Methods of making articles and methods of using articles to treat wounds are described.
HYALURONIC ACID BINDING PEPTIDE AS A THERAPEUTIC TO CONTROL FIBROBLAST ACTIVATION AND FIBROTIC CAPSULE FORMATION
Articles, such as implants and medical devices, treated with a hyaluronic acid binding peptide are provided. Articles are coated with a surface functionalizing agent which bind to and immobilize the hyaluronic acid binding peptide. Methods of improving and/or reducing foreign body reaction to an article are also provided, as are methods of decreasing inflammation, promoting wound healing, and treating dermal conditions.
Polymer based hydrogel
The present invention relates to an anti-aging antimicrobial wound healing polymer based hydrogel. In the study of the present invention, a wound healing gel formulation is developed by combining poloxamer polymers and boron component at adequate concentrations in a carbopol based gel. The said gel exhibits fast action on the damaged area and prevents scar formation.
HEMOSTATIC MIXTURE OF CELLULOSE-BASED SHORT AND LONG FIBERS
The invention relates to a hemostatic composition comprising a mixture of cellulose-based short and long fibers, preparation and use thereof.
HEMOSTATIC COMPOSITION
The present invention relates to improved hemostatic compositions comprising cellulose-based fibers supplemented with compounds, preparation and use thereof.
Silver oxide formulations
Topical formulations for application to exposed body tissue.
Hydrogel Composites, Compositions, and Methods
Provided herein are methods for treating, adhering, or sealing biological tissue with a material, such as a hydrogel, that may include phyllosilicate nanoplatelets. The phyllosilicate nanoplatelets can have a high aspect ratio, a low aspect ratio, or be a mixture of high aspect ratio and low aspect ratio nanoplatelets. Drug releasing compositions and kits also are provided herein.